| Biological Information | |
|---|---|
| Background Information: | CXCL13 is a small cytokine protein that is selectively chemotactic for B cells belonging to both the B-1 and B-2 subsets, and carries out its effects by interacting with its chemokine receptor, CXCR5. It takes part in the formation of ectopic lymphoid tissue in chronic inflammation and is expressed highly in the liver, spleen, lymph nodes, and the gut of humans. Provided as 20 μg of dry powder alongside reconstitution buffer. |
| Target Class: | Chemokine |
| Family: | Chemokine Receptors |
| Target Name: | CXCL13 |
| Usage | |
| Product Type: | Recombinant Proteins |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Recombinant Human CXCL13
Recombinant Human CXCL13 is an agonist for CXCR5. This product is provided as 20μg of dry powder alongside reconstitution buffer.
Datasheets
92-1012 Datasheet
View Document